[Lipid-lowering effect of etofibrate, bezafibrate and xanthinol nicotinate in patients with hyperlipoproteinemias]

Ther Ggw. 1982 May;121(5):301-11.
[Article in German]
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Bezafibrate
  • Cholesterol / metabolism
  • Cholesterol, HDL
  • Cholesterol, LDL
  • Cholesterol, VLDL
  • Clofibrate / analogs & derivatives*
  • Clofibric Acid / analogs & derivatives*
  • Clofibric Acid / therapeutic use
  • Female
  • Humans
  • Hyperlipoproteinemias / drug therapy*
  • Hypolipidemic Agents / therapeutic use*
  • Lipoproteins, HDL / metabolism
  • Lipoproteins, LDL / metabolism
  • Lipoproteins, VLDL / metabolism
  • Male
  • Middle Aged
  • Theophylline / analogs & derivatives*
  • Xanthinol Niacinate / therapeutic use*

Substances

  • Cholesterol, HDL
  • Cholesterol, LDL
  • Cholesterol, VLDL
  • Hypolipidemic Agents
  • Lipoproteins, HDL
  • Lipoproteins, LDL
  • Lipoproteins, VLDL
  • etofibrate
  • Clofibric Acid
  • Xanthinol Niacinate
  • Cholesterol
  • Theophylline
  • Clofibrate
  • Bezafibrate